Hims & Hers Health Inc (NYSE:HIMS) shares traded 4.43% higher at $38.93 on Wall Street last session.
HIMS stock price is now 33.48% away from the 50-day moving average and 84.30% away from the 200-day moving average. The market capitalization of the company currently stands at $8.51B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target enhanced from $24 to $25, Citigroup Downgraded its rating from Neutral to Sell for Hims & Hers Health Inc (NYSE: HIMS). On January 07, 2025, BTIG Research recently initiated its ‘Buy’ rating on the stock quoting a target price of $35, while ‘Morgan Stanley’ rates the stock as ‘Overweight’
In other news, Boughton Soleil, Officer bought 4,153 shares of the company’s stock on Feb 03 ’25. The stock was bought for $146,601 at an average price of $35.30. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 03 ’25, Officer Chi Michael bought 2,054 shares of the business’s stock. A total of $72,506 was incurred on buying the stock at an average price of $35.30. A total of 18.75% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $8.51 and a high of $37.96. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 2.14, and a quick ratio of 1.82. The fifty day moving average price for HIMS is $28.8072 and a two-hundred day moving average price translates $20.9915 for the stock.
The latest earnings results from Hims & Hers Health Inc (NYSE: HIMS) was released for 2024-09-30. The net profit margin was 8.15% and return on equity was 26.35% for HIMS. The company reported revenue of $401.56 million for the quarter, compared to $226.7 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 77.13 percent. For the current quarter, analysts expect HIMS to generate $469.68M in revenue.
